factor de crecimiento nervioso

Article

Gambogic amide, a selective TrkA agonist, does not improve outcomes from traumatic brain injury in mice.

Autor/s:

Johnstone MR, Sun M, Taylor CJ, Brady RD, Grills BL, Church JE, Shultz SR, McDonald SJ.

Any publicació:

2018

Número de revista:

Brain Injury vol. 32 n. 2

http://www.tandfonline.com/doi/full/10.1080/02699052.2017.1394492

Article

Intranasal Nerve Growth Factor administration improves cerebral functions in a child with severe traumatic brain injury: A case report.

Autor/s:

Chiaretti A, Conti G, Falsini B, Buonsenso D, Crasti M, Manni L, Soligo M, Fantacci C, Genovese O, Calcagni ML, Di Giuda D, Mattoli MV, Cocciolillo F, Ferrara P, Ruggiero A, Staccioli S, Colafati GS, Riccardi R.

Any publicació:

2017

Número de revista:

Brain Injury vol. 31 n. 11

http://www.tandfonline.com/doi/full/10.1080/02699052.2017.1376760

Una iniciativa de:

Cercador

Gambogic amide, a selective TrkA agonist, does not improve outcomes from traumatic brain injury in mice.

Intranasal Nerve Growth Factor administration improves cerebral functions in a child with severe traumatic brain injury: A case report.

Trobes a faltar informació? Fes-nos arribar els teus suggeriments!